Marc Blaustein - Net Worth and Insider Trading

Marc Blaustein Net Worth

The estimated net worth of Marc Blaustein is at least $2,152 dollars as of 2024-05-24. Marc Blaustein is the COO of Finch Therapeutics Group Inc and owns about 1,087 shares of Finch Therapeutics Group Inc (FNCH) stock worth over $2,152. Details can be seen in Marc Blaustein's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Marc Blaustein has not made any transactions after 2022-10-21 and currently still holds the listed stock(s).

Transaction Summary of Marc Blaustein

To

Marc Blaustein Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Marc Blaustein owns 1 companies in total, including Finch Therapeutics Group Inc (FNCH) .

Click here to see the complete history of Marc Blaustein’s form 4 insider trades.

Insider Ownership Summary of Marc Blaustein

Ticker Comapny Transaction Date Type of Owner
FNCH Finch Therapeutics Group Inc 2022-10-21 Chief Operating Officer

Marc Blaustein Latest Holdings Summary

Marc Blaustein currently owns a total of 1 stock. Marc Blaustein owns 1,087 shares of Finch Therapeutics Group Inc (FNCH) as of October 21, 2022, with a value of $2,152.

Latest Holdings of Marc Blaustein

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
FNCH Finch Therapeutics Group Inc 2022-10-21 1,087 1.98 2,152

Holding Weightings of Marc Blaustein


Marc Blaustein Form 4 Trading Tracker

According to the SEC Form 4 filings, Marc Blaustein has made a total of 1 transactions in Finch Therapeutics Group Inc (FNCH) over the past 5 years, including 0 buys and 1 sells. The most-recent trade in Finch Therapeutics Group Inc is the sale of 121 shares on October 21, 2022, which brought Marc Blaustein around $5,054.

Insider Trading History of Marc Blaustein

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Marc Blaustein Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Marc Blaustein Ownership Network

Ownership Network List of Marc Blaustein

No Data

Ownership Network Relation of Marc Blaustein


Marc Blaustein Owned Company Details

What does Finch Therapeutics Group Inc do?

Who are the key executives at Finch Therapeutics Group Inc?

Marc Blaustein is the Chief Operating Officer of Finch Therapeutics Group Inc. Other key executives at Finch Therapeutics Group Inc include Chief Financial Officer Lance E Thibault , Chief Executive Officer Matthew P. Blischak , and Chief Business & Legal Officer Joseph Vittiglio .

Finch Therapeutics Group Inc (FNCH) Insider Trades Summary

Over the past 18 months, Marc Blaustein made no insider transaction in Finch Therapeutics Group Inc (FNCH). Other recent insider transactions involving Finch Therapeutics Group Inc (FNCH) include a net sale of 9,712 shares made by Jeffery A Smisek , and a net purchase of 5,010 shares made by Susan E Graf .

In summary, during the past 3 months, insiders sold 8,242 shares of Finch Therapeutics Group Inc (FNCH) in total and bought 0 shares, with a net sale of 8,242 shares. During the past 18 months, 9,712 shares of Finch Therapeutics Group Inc (FNCH) were sold and 167 shares were bought by its insiders, resulting in a net sale of 9,545 shares.

Finch Therapeutics Group Inc (FNCH)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Finch Therapeutics Group Inc Insider Transactions

No Available Data

Marc Blaustein Mailing Address

Above is the net worth, insider trading, and ownership report for Marc Blaustein. You might contact Marc Blaustein via mailing address: C/o Finch Therapeutics Group, Inc., 200 Inner Belt Road, Suite 400, Somerville Ma 02143.

Discussions on Marc Blaustein

No discussions yet.